Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02000934
Title A Study of TAK-659 in Adult Patients With Advanced Solid Tumor and Lymphoma Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

chronic lymphocytic leukemia

mantle cell lymphoma

lymphoplasmacytic lymphoma

Advanced Solid Tumor

diffuse large B-cell lymphoma

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

Therapies

Mivavotinib

Age Groups: adult
Covered Countries USA | ITA | ESP


No variant requirements are available.